CClinicalTrials.gg
CompletedNCT06966011Updated Apr 3, 2026

Rebound Pain After Peripheral Nerve Blocks in Total Knee Arthroplasty

An observational study in Total Knee Arthroplasty, Postoperative Pain and Rebound Pain, sponsored by Konya City Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-04-03.

Sponsored by Konya City Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
294
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This prospective observational study aims to determine the incidence and clinical impact of rebound pain after peripheral nerve blocks in patients undergoing total knee arthroplasty. Rebound pain is defined as a sudden, severe pain (NRS ≥7) emerging after block resolution. Primary outcome is the incidence of rebound pain; secondary outcomes include pain severity, rescue analgesia use, nausea, vomiting, sleep quality, and patient satisfaction.

02

Conditions studied

  • Total Knee Arthroplasty
  • Postoperative Pain
  • Rebound Pain
  • Peripheral Nerve Block
  • Pain Management
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 294 is above the median of 102 across 608 observational studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Konya City Hospital is the lead sponsor of 76 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of adult patients aged 18 to 70 years who are scheduled for elective unilateral total knee arthroplasty under spinal anesthesia at a tertiary care hospital. All participants will receive peripheral nerve blocks as part of a standardized multimodal analgesia protocol. Patients must be physically and cognitively able to provide consent and complete a postoperative pain diary. Those with contraindications to regional anesthesia, allergies to local anesthetics, or significant comorbidities (ASA IV and above) will be excluded.

Inclusion criteria

  • Age between 18 and 70 years
  • ASA physical status I to III
  • Scheduled for elective unilateral total knee arthroplasty under spinal anesthesia
  • Peripheral nerve block (PNB) planned as part of multimodal analgesia
  • Ability to understand and provide written informed consent
  • Willingness and ability to complete the postoperative pain diary

Exclusion criteria

Exclusion Criteria:

  • Known allergy or hypersensitivity to local anesthetics
  • Contraindication to regional anesthesia
  • ASA physical status IV or higher
  • Neurological or psychiatric disorders interfering with study participation or pain reporting
  • Use of anticoagulants or presence of coagulopathy
  • Use of medications that may alter pain perception or rebound pain response
  • Local infection at the block site
  • Emergency surgeries
  • Inability or unwillingness to complete the postoperative pain diary or follow-up
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
294 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Incidence of Rebound Pain After Peripheral Nerve Block

    Rebound pain is defined as a sudden, severe increase in pain occurring after the resolution of peripheral nerve block, typically within 12-24 hours postoperatively. Pain intensity will be assessed using the Numeric Rating Scale (NRS; 0 = no pain, 10 = worst imaginable pain). A score of NRS ≥7 will be considered as severe pain. Patients will record pain scores in a pain diary, and incidence will be calculated as the proportion of patients meeting the rebound pain criteria.

    Time frame: Within 48 hours after surgery

Secondary outcomes

  1. Sleep Quality

    Sleep quality will be assessed using a 6-item sleep questionnaire (scored 1-6, where 1 = best and 6 = worst sleep quality), covering the night before surgery and the first 7 nights postoperatively.

    Time frame: From 1 day before surgery to postoperative day 7

  2. Patient Satisfaction with Pain Management

    Patients will rate their satisfaction with postoperative pain control on a 5-point Likert scale (1 = not at all satisfied, 5 = completely satisfied).

    Time frame: Postoperative day 7 (via telephone follow-up)

  3. Total Rescue Analgesic Consumption

    The total dose of rescue opioid analgesics administered within the first 48 hours postoperatively will be recorded in milligrams.

    Time frame: Within 48 hours after surgery

  4. Time to First Rescue Analgesia

    Time elapsed from the end of surgery to the first administration of rescue analgesia will be recorded.

    Time frame: Within 48 hours after surgery

07

Study locations

1 site
  • Konya City Hospital
    Konya, 42090, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — This study does not plan to share individual participant data due to institutional policies and patient confidentiality considerations.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06966011
Lead sponsor
Konya City Hospital
Responsible party
Mahmut Sami TUTAR (Associate Professor, Department of Anesthesiology and Reanimation, Konya City Hospital) — Principal investigator
First posted
May 11, 2025
Start date
May 21, 2025
Primary completion
Mar 3, 2026
Completion
Mar 3, 2026
Last update
Apr 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion